Structured Product Labeling Resources
The Structured Product Labeling (SPL) is a document markup standard approved by Health Level Seven (HL7) and adopted by FDA as a mechanism for exchanging product and facility information.
SPL Guidance Documents
- Compounding Animal Drugs from Bulk Drug Substances (draft guidance)
- DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics (draft guidance)
- Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act (final guidance)
- Electronic Submission of Lot Distribution Reports (final guidance)
- Format and Content of a REMS Document (draft guidance)
- Indexing Structured Product Labeling (final guidance)
- Providing Regulatory Submissions in Electronic Format - Content of Labeling (final guidance)
- Providing Regulatory Submissions in Electronic Format - Content of the Risk Evaluation and Mitigation Strategies Document Using Structured Product Labeling (final guidance)
- Providing Regulatory Submissions in Electronic Format - Drug Establishment Registration and Drug Listing (final guidance)
- Public Availability of Labeling Changes in “Changes Being Effected” Supplements (draft guidance)
- Registration and Listing of Cosmetic Product Facilities and Products (draft guidance)
- Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act (final guidance)
- Self-Identification of Generic Drug Facilities, Sites, and Organizations (draft guidance)
- SPL Standard for Content of Labeling Technical Questions and Answers (draft guidance)
SPL Implementation Guide and Validation Procedures
- SPL Implementation Guide with Validation Procedures v1.0
- Step-by-Step Instructions for Creating SPL Files for Drug Establishment Registration and Drug Listing v2.0
GDUFA SPL Step-by-Step Instructions & Technical Specifications
- GDUFA Self ID SPL Industry Technical Specification Information (PDF)
- GDUFA SPL Step-by-Step Instructions for Self-Identification of Facilities, Sites, and Organizations (PDF)
SPL Dockets
- SPL Docket 92S-0251 - Drug Establishment Registration and Drug Listing (PDF)
- SPL Docket 92S-0251 - Content of Labeling-CDER (PDF))
- SPL Docket 92S-0251 - Content of Labeling - CBER (PDF)
- SPL Docket 92S-0251 - Blood and Tissue Establishment Registration and Product Listing (PDF
SPL Schema and Stylesheet
- FDA SPL Schema for Implementation (zip file last updated April 25, 2016)
- FDA SPL stylesheet (zip file last updated October 24, 2016) - send comments to spl@fda.hhs.gov
Download Labeling
- FDALabel: FDA’s web-based application designed to perform customizable searches of over 140,000 labeling for human prescription drug; nonprescription drugs; and labeling for other products (e.g., animal nonprescription and animal prescription drugs, cosmetics, dietary supplements, medical devices, medical foods). FDALabel and DailyMed have the same database but have different search functions and different displays of search results.
- FDA Online Label Repository
Resources
- Comprehensive NDC SPL Data Elements File (NSDE)
- Indexing SPL Fact Sheet
- SPL Standard Training
- SPL Xforms
- SPL Training Material
- FDA Electronic Secure Gateway
- SPL Software and Conversion Vendors
- CDER Direct
- CVM SPL Xforms
- REMS SPL Resources
SPL Terminology
- Business Entity Identifiers
- Business Operation
- Business Operation Qualifier
- Code system object identifiers (OIDs)
- Color
- Combination Product Types
- Cosmetic Product Categories and Codes
- Document Type including Content of Labeling Type
- Dosage form
- Equivalence Codes
- Flavor
- Geopolitical Entities, Names, and Codes (GENC)
- Lot Distribution Data - Distribution Codes
- Marketing Category
- Marketing Status
- Package type
- Route of administration
- Section headings
- Shape
- SPL DEA Schedule
- Time Units: Unified Code for Units of Measure (UCUM)
- UNIIs, Preferred Substance Names, and their Identified Synonyms
- Units of measure
- Units of presentation
SPL Terminology Files for Validation
- Action (XML)
- Active Ingredient-Active Moiety Relationship/Basis of Strength (Excel & XML)(Not applicable for SPL files w/bulk ingredient marketing category.)
- Additional Validation Files (XML)
- Blood Donor Type (Excel and XML)
- Blood Product Type (Excel and XML)
- Business Operation Qualifiers (XML)
- Combination Product Category Types (XML and Excel)
- Cosmetic Product Categories and Codes (XML and Excel)
- DEA Schedule
- Device Product Classification
- Designated Medical Gas
- Dosage Form (XML)
- Lot Distribution Data - Distribution Codes
- Marketing Categories (XML)
- Medication Guides (Excel and XML)
- Physician Labeling Rule Content of Labeling & Application Number Validation (Excel and XML)
- Product Concept Validation (CSV)
- REMS Approval (XML)
- REMS Protocol (XML)
- REMS Requirements (XML)
- REMS Stakeholder (XML)
- SPL Terminology Validation Files (XML)
- Tissue Donor Type (Excel and XML)
- Tissue Establishment Function Type (Excel and XML)
- Tissue Establishment Type (Excel and XML)
- Tissue Product Group (Excel and XML)
- Tissue Product Type (Excel and XML)
- Unique Ingredient Identifiers (UNII) (XML and CSV)
- Vaccine Substances Validation File (XML and CSV)
Terminology for Indexing SPL
- Contributing Factor - General
- Indication Category
- Intent of Use
- Lab Test
- Limitation of Use/Issues
- Medical Condition
- Pharmacokinetic Effect
- Pharmacologic Class
- Precondition Categories
- Race
- Sex
- Type of Consequence
Contact Information
Questions regarding SPL submissions should be directed to: spl@fda.hhs.gov.